
Andlauer Healthcare Group Inc.
AND.TOTSXIndustrials
$54.97
+$0.00(+0.00%)
Market Cap$2.2B
P/E Ratio—
52W High$55.1
52W Low$36.68
Andlauer Healthcare Group Inc.(AND.TO)· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。
FMP · AND.TO · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.65B | $0.65B | $0.65B | $0.44B | $0.31B |
| Cost of Revenue | $0.50B | $0.50B | $0.49B | $0.33B | $0.23B |
| Gross Profit | $0.15B | $0.15B | $0.16B | $0.11B | $0.08B |
| Gross Margin %(computed) | 22.63% | 22.76% | 24.50% | 25.16% | 25.31% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.05B | $0.05B | $0.05B | $0.04B | $0.03B |
| Operating Income | $0.09B | $0.10B | $0.11B | $0.07B | $0.05B |
| Operating Margin %(computed) | 14.45% | 14.82% | 17.02% | 16.75% | 16.21% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.01B | $0.01B | $0.01B | $0.01B | $0.00B |
| Income Before Tax | $0.09B | $0.09B | $0.10B | $0.11B | $0.05B |
| Income Tax Expense | $0.02B | $0.02B | $0.03B | $0.02B | $0.01B |
| Net Income | $0.06B | $0.07B | $0.08B | $0.09B | $0.04B |
| Net Margin %(computed) | 9.91% | 10.21% | 11.76% | 20.44% | 12.00% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $1.60 | $1.58 | $1.82 | $2.30 | $1.00 |
| Wtd Avg Shares | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B |
| EBITDA | $0.17B | $0.17B | $0.18B | $0.16B | $0.08B |
| EBITDA Margin %(computed) | 25.63% | 25.77% | 27.00% | 35.76% | 25.19% |
数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · CAD · B
深入了解Andlauer Healthcare Group Inc.
关于Andlauer Healthcare Group Inc.(AND.TO)损益表
Andlauer Healthcare Group Inc.(AND.TO)损益表数据来源于SEC Form 10-K及10-Q申报文件。2024财年,AND.TO实现营收$0.65B,毛利润$0.15B(毛利率22.63%),净利润$0.06B(净利率9.91%)。
常见问题
AND.TO · 4 问Andlauer Healthcare Group Inc.(AND.TO)2024财年营收为$0.65B,同比up0.4%。
AND.TO revenueAND.TO salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08